10x Genomics, Inc. (TXG): Shareholders' Equity
$796.33M
As of 2025-12-31
$825.55M
As of 2026-06-30
-0.4%
3-year compound annual growth
+1.5%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $796.33M | +12.1% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $710.13M | -4.2% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $741.04M | -8.0% | 2026-02-13, Balance as of period end |
| 2022-12-31 | $805.74M | -1.4% | 2025-02-13, Balance as of period end |
| 2021-12-31 | $817.57M | +10.6% | 2024-02-15, Balance as of period end |
| 2020-12-31 | $739.07M | +75.9% | 2023-02-16, Balance as of period end |
| 2019-12-31 | $420.08M | n/m | 2022-02-18, Balance as of period end |
| 2018-12-31 | -$219.99M | n/m | 2021-02-26, Balance as of period end |
| 2017-12-31 | -$112.51M | n/a | 2020-02-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $796.33M | +12.1% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $341.74M | -13.6% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $5.35M | -98.9% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $7.45B | +13.5% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $7.25B | -5.4% |
| Quanterix Corp (QTRX) | 2025-12-31 | $295.73M | -10.4% |
| Waters Corp (WAT) | 2025-12-31 | $2.56B | +40.1% |
| Bruker Corp (BRKR) | 2025-12-31 | $2.47B | +37.6% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | -$23.64M | n/m |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗